Article

What Is the Difference Between Triple-Negative and Basal Breast Cancers?

2010-01-01

Abstract excerpt

Triple-negative breast cancer (TNBC) represents a phenotype defined by the lack of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor-2 expression. Because TNBCs have more aggressive features and lack a therapeutic target, they have become a key topic of clinical and research interest within the oncology community. With advancements in the field of molecular biology, gene expressi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: cb7ed474-1373-5941-bc49-a7cdbc57aec0
DOI: 10.1097/ppo.0b013e3181cf04be

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

What Is the Difference Between Triple-Negative and Basal Breast Cancers?DOI 10.1097/ppo.0b013e3181cf04beRead

How basal are triple-negative breast cancers?Semantic proximity Read

Basal breast cancer: a complex and deadly molecular subtype.Semantic proximity Read

Triple-negative breast cancer.Semantic proximity Read

Advances in the Understanding of the Pathogenesis of Triple-Negative Breast Cancer.Semantic proximity Read

Targeting basal-like breast cancers.Semantic proximity Read

Update on triple‐negative breast cancers – highlighting subtyping update and treatment implicationSemantic proximity Read

Basal phenotype breast cancer: implications for treatment and prognosis.Semantic proximity Read

Triple negative breast carcinoma and the basal phenotype: from expression profiling to clinical practice.Semantic proximity Read

Triple-Negative Breast Cancer: Molecular Particularities Still a ChallengeSemantic proximity Read

Triple-negative breast cancer: unique biology and its management.Semantic proximity Read

[Triple-negative breast cancer : Classification, current concepts, and therapy-related factors].Semantic proximity Read

Minireview: Basal-Like Breast Cancer: From Molecular Profiles to Targeted TherapiesSemantic proximity Read